Date Initiated by Firm |
March 10, 2010 |
Date Posted |
April 18, 2012 |
Recall Status1 |
Terminated 3 on April 18, 2012 |
Recall Number |
Z-1434-2012 |
Recall Event ID |
55440 |
510(K)Number |
K981758
|
Product Classification |
Bromcresol green dye-binding, albumin - Product Code CIX
|
Product |
Clinical Chemistry Albumin BCG (AlbG) List Number 7D53-21 Clinical Chemistry Albumin BCG 510(k) K981758, Product Code CIX
The Albumin BCG assay is used for the quantitation of albumin in human serum or plasma |
Code Information |
Lot Numbers: 77056HW00; 80051HW00; 83030HW00 Exp dates: 04/15/2011, 07/15/2011, and 10/10/2011, respectively. |
Recalling Firm/ Manufacturer |
Abbott Laboratories Inc. 820 Mission St South Pasadena CA 91030-3142
|
For Additional Information Contact |
626-440-0705
|
Manufacturer Reason for Recall |
Observed particulate matter in some reagent cartridges.
|
FDA Determined Cause 2 |
Material/Component Contamination |
Action |
Abbott Laboratories sent a Product Recall notification letter dated March 10, 2010, to all affected customers. The notification letter contained an explanation, patient impact, neccassary actions, and contact information.
Customers were instructed to determine if they currently have any of the affected product in their inventory. Discontinue use and destroy any remaining inventory of the affected product in accordance with their institution's policies and procedures. Completed the enclosed Customer Reply Form. If customers forwarded any of the affected product they should provide a copy of the notification letter to their customers.
For any questions customers should call Customer Service at 1-877-422-2688.
For questions regarding this recall call 626-440-0705. |
Quantity in Commerce |
2718 (U.S. 652) |
Distribution |
US nationwide and internationally to Germany, Hong Kong, Australia, New Zealand, Trinidad/Tobago, and Jamaica. No dsitribution of Canada or Mexica. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = CIX and Original Applicant = ABBOTT LABORATORIES
|